Case Study Creation for Talosix EDC
Purpose
Produce customer case studies that demonstrate measurable impact of Talosix EDC on clinical trial operations. Case studies serve as mid-to-bottom funnel content for prospects evaluating EDC platforms, used by sales, marketing, and business development teams.
Case Study Structure
Standard Format: Problem / Solution / Results
1. Header Block
- Title: Action-oriented, include key metric if possible
- Example: "Mid-Size CRO Reduces Study Build Time by 60% with Talosix EDC"
- Subtitle: One sentence elaborating on the context
- Quick stats sidebar: 3-4 headline metrics
- Customer profile: Organization type, size, therapeutic area, trial phase
2. Customer Profile (2-3 sentences)
- Organization type (sponsor, CRO, academic medical center, site network)
- Size and scope (number of trials, geography, therapeutic focus)
- Relevant context (growth stage, regulatory environment, portfolio complexity)
- NOTE: Anonymize or use approved customer name per agreement
3. The Challenge (200-300 words)
- Specific operational pain points before Talosix
- Quantify the problem where possible (time, cost, error rates, delays)
- Regulatory or compliance pressures
- Previous solution limitations
- Business impact of the status quo
4. The Solution (300-400 words)
- Why Talosix was selected (evaluation criteria, competitive differentiators)
- Implementation approach and timeline
- Key features or capabilities leveraged
- Integration with existing systems (CTMS, IRT/IWRS, safety databases, labs)
- Validation and go-live process
- Training and change management approach
5. The Results (200-300 words)
- Quantified outcomes with before/after comparisons
- Operational efficiency gains
- Data quality improvements
- Compliance and audit outcomes
- User adoption and satisfaction indicators
- Timeline from implementation to value realization
6. Customer Quote
- Direct quote from a named stakeholder (with approval) or anonymized role
- Should reinforce the most compelling result
- Keep to 2-3 sentences maximum
7. Call to Action
- Link to request a demo or speak with sales
- Link to related content (white paper, product page, webinar recording)
Key Metrics to Capture and Highlight
Study Build and Setup
- Study build time reduction (days/weeks saved)
- Number of eCRF iterations before finalization
- Time from protocol to first patient data entry
- Library/template reuse rate
Data Quality
- Query rate reduction (queries per subject or per page)
- Data entry error rate (before vs. after)
- Auto-query vs. manual query ratio
- Time to query resolution
- Percentage of clean data at database lock
Operational Efficiency
- Database lock cycle time reduction
- Number of studies managed per data manager
- Reduction in duplicate data entry
- Site training time to proficiency
- CRA monitoring visit preparation time
Compliance and Audit
- Audit findings related to EDC (before vs. after)
- 21 CFR Part 11 compliance audit outcomes
- CDISC compliance rate (CDASH, SDTM mapping accuracy)
- Inspection readiness score improvements
Cost Impact
- Total cost of ownership comparison
- Per-study or per-subject cost reduction
- FTE time savings (translated to dollar value)
- Vendor consolidation savings
Anonymization Guidelines
When Customer Allows Full Attribution
- Use company name, logo, and spokesperson name/title
- Reference specific therapeutic areas and trial phases
- Include exact metrics
- Customer reviews and approves final version
When Partial Anonymization Required
- Use descriptive identifiers: "A Top-20 Global CRO" or "A Mid-Size Oncology Sponsor"
- Generalize therapeutic area if needed: "oncology" rather than specific indication
- Use role titles without names: "VP of Clinical Data Management"
- Round metrics to nearest 5% or 10% to prevent identification
- Remove geographic specifics if identifying
When Full Anonymization Required
- Use generic descriptors: "A pharmaceutical company"
- Aggregate metrics across multiple customers if needed
- No identifying details about trial portfolio
- Focus on general capability demonstration
- Consider composite case study approach (clearly labeled)
Approval Workflow
Internal Steps
- Sales/CSM identifies candidate — Flags customer with strong results and relationship
- Marketing drafts interview questions — Tailored to known outcomes and use case
- Customer interview conducted — 30-45 minute structured interview
- Draft written — Following standard format above
- Internal review — Marketing, product, and sales review for accuracy
- Legal review — Check claims, compliance language, contractual obligations
Customer Approval Steps
- Send draft to customer contact — With clear markup of quotes and attributions
- Customer internal review — Allow 2-3 weeks for legal/PR review on their side
- Incorporate feedback — Adjust per customer requests
- Final sign-off — Written approval (email sufficient) before any publication
- Annual re-approval — Check annually that customer is still comfortable with content
Approval Tracking
- Maintain a log of: customer name, case study title, approval date, approver name/role, approved channels (web, print, sales deck, conference), expiration/review date
Tone and Style
- Professional and credible — This is B2B content for clinical trial professionals
- Metrics-driven — Lead with numbers, support with narrative
- Respectful of customer — They are the hero, Talosix is the enabler
- Specific over general — "Reduced query rate from 12.3 to 4.1 per subject" beats "significantly improved data quality"
- Avoid superlatives — No "best," "only," "first" unless verifiably true
- Regulatory precision — Do not overstate compliance claims
Distribution Channels
- Website resource library — Gated (require email) or ungated based on strategy
- Sales enablement — PDF format for email attachment, one-pager for meetings
- Conference materials — Printed or digital for booth and session handouts
- Social media — Pull 2-3 key stats for LinkedIn posts with link to full study
- Email campaigns — Include in nurture sequences matched to similar prospect profiles
- Webinars — Customer co-presentation format for high-value case studies
Output Deliverables
When creating a case study, produce:
- Full case study document (800-1,200 words)
- One-page summary version (PDF-ready, 400-500 words)
- Key stats card (3-4 metrics with visual layout guidance)
- Two LinkedIn post variants promoting the case study
- Email snippet for sales team to share with prospects
- Interview question template (if interview has not yet been conducted)
1---2name: case-study-creation3description: Create compelling customer case studies for Talosix EDC using problem/solution/results format with clinical trial metrics, appropriate anonymization, and approval workflows.4---56# Case Study Creation for Talosix EDC78## Purpose910Produce customer case studies that demonstrate measurable impact of Talosix EDC on clinical trial operations. Case studies serve as mid-to-bottom funnel content for prospects evaluating EDC platforms, used by sales, marketing, and business development teams.1112## Case Study Structure1314### Standard Format: Problem / Solution / Results1516**1. Header Block**17- Title: Action-oriented, include key metric if possible18 - Example: "Mid-Size CRO Reduces Study Build Time by 60% with Talosix EDC"19- Subtitle: One sentence elaborating on the context20- Quick stats sidebar: 3-4 headline metrics21- Customer profile: Organization type, size, therapeutic area, trial phase2223**2. Customer Profile (2-3 sentences)**24- Organization type (sponsor, CRO, academic medical center, site network)25- Size and scope (number of trials, geography, therapeutic focus)26- Relevant context (growth stage, regulatory environment, portfolio complexity)27- NOTE: Anonymize or use approved customer name per agreement2829**3. The Challenge (200-300 words)**30- Specific operational pain points before Talosix31- Quantify the problem where possible (time, cost, error rates, delays)32- Regulatory or compliance pressures33- Previous solution limitations34- Business impact of the status quo3536**4. The Solution (300-400 words)**37- Why Talosix was selected (evaluation criteria, competitive differentiators)38- Implementation approach and timeline39- Key features or capabilities leveraged40- Integration with existing systems (CTMS, IRT/IWRS, safety databases, labs)41- Validation and go-live process42- Training and change management approach4344**5. The Results (200-300 words)**45- Quantified outcomes with before/after comparisons46- Operational efficiency gains47- Data quality improvements48- Compliance and audit outcomes49- User adoption and satisfaction indicators50- Timeline from implementation to value realization5152**6. Customer Quote**53- Direct quote from a named stakeholder (with approval) or anonymized role54- Should reinforce the most compelling result55- Keep to 2-3 sentences maximum5657**7. Call to Action**58- Link to request a demo or speak with sales59- Link to related content (white paper, product page, webinar recording)6061## Key Metrics to Capture and Highlight6263### Study Build and Setup64- Study build time reduction (days/weeks saved)65- Number of eCRF iterations before finalization66- Time from protocol to first patient data entry67- Library/template reuse rate6869### Data Quality70- Query rate reduction (queries per subject or per page)71- Data entry error rate (before vs. after)72- Auto-query vs. manual query ratio73- Time to query resolution74- Percentage of clean data at database lock7576### Operational Efficiency77- Database lock cycle time reduction78- Number of studies managed per data manager79- Reduction in duplicate data entry80- Site training time to proficiency81- CRA monitoring visit preparation time8283### Compliance and Audit84- Audit findings related to EDC (before vs. after)85- 21 CFR Part 11 compliance audit outcomes86- CDISC compliance rate (CDASH, SDTM mapping accuracy)87- Inspection readiness score improvements8889### Cost Impact90- Total cost of ownership comparison91- Per-study or per-subject cost reduction92- FTE time savings (translated to dollar value)93- Vendor consolidation savings9495## Anonymization Guidelines9697### When Customer Allows Full Attribution98- Use company name, logo, and spokesperson name/title99- Reference specific therapeutic areas and trial phases100- Include exact metrics101- Customer reviews and approves final version102103### When Partial Anonymization Required104- Use descriptive identifiers: "A Top-20 Global CRO" or "A Mid-Size Oncology Sponsor"105- Generalize therapeutic area if needed: "oncology" rather than specific indication106- Use role titles without names: "VP of Clinical Data Management"107- Round metrics to nearest 5% or 10% to prevent identification108- Remove geographic specifics if identifying109110### When Full Anonymization Required111- Use generic descriptors: "A pharmaceutical company"112- Aggregate metrics across multiple customers if needed113- No identifying details about trial portfolio114- Focus on general capability demonstration115- Consider composite case study approach (clearly labeled)116117## Approval Workflow118119### Internal Steps1201. **Sales/CSM identifies candidate** — Flags customer with strong results and relationship1212. **Marketing drafts interview questions** — Tailored to known outcomes and use case1223. **Customer interview conducted** — 30-45 minute structured interview1234. **Draft written** — Following standard format above1245. **Internal review** — Marketing, product, and sales review for accuracy1256. **Legal review** — Check claims, compliance language, contractual obligations126127### Customer Approval Steps1287. **Send draft to customer contact** — With clear markup of quotes and attributions1298. **Customer internal review** — Allow 2-3 weeks for legal/PR review on their side1309. **Incorporate feedback** — Adjust per customer requests13110. **Final sign-off** — Written approval (email sufficient) before any publication13211. **Annual re-approval** — Check annually that customer is still comfortable with content133134### Approval Tracking135- Maintain a log of: customer name, case study title, approval date, approver name/role, approved channels (web, print, sales deck, conference), expiration/review date136137## Tone and Style138139- **Professional and credible** — This is B2B content for clinical trial professionals140- **Metrics-driven** — Lead with numbers, support with narrative141- **Respectful of customer** — They are the hero, Talosix is the enabler142- **Specific over general** — "Reduced query rate from 12.3 to 4.1 per subject" beats "significantly improved data quality"143- **Avoid superlatives** — No "best," "only," "first" unless verifiably true144- **Regulatory precision** — Do not overstate compliance claims145146## Distribution Channels147148- **Website resource library** — Gated (require email) or ungated based on strategy149- **Sales enablement** — PDF format for email attachment, one-pager for meetings150- **Conference materials** — Printed or digital for booth and session handouts151- **Social media** — Pull 2-3 key stats for LinkedIn posts with link to full study152- **Email campaigns** — Include in nurture sequences matched to similar prospect profiles153- **Webinars** — Customer co-presentation format for high-value case studies154155## Output Deliverables156157When creating a case study, produce:1581. Full case study document (800-1,200 words)1592. One-page summary version (PDF-ready, 400-500 words)1603. Key stats card (3-4 metrics with visual layout guidance)1614. Two LinkedIn post variants promoting the case study1625. Email snippet for sales team to share with prospects1636. Interview question template (if interview has not yet been conducted)